Cargando…
Loss of Disabled-2 Expression in Pancreatic Cancer Progression
Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive cancer type characterized by rapid metastasis and resistance to chemotherapy, properties that are shared by cancer stem cells (CSCs). In pancreatic cancer, tumor cells which possess the properties of CSCs also phenotypically resemble cel...
Autor principal: | Hocevar, Barbara A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6525241/ https://www.ncbi.nlm.nih.gov/pubmed/31101868 http://dx.doi.org/10.1038/s41598-019-43992-z |
Ejemplares similares
-
Loss of HNF6 expression correlates with human pancreatic cancer progression
por: Pekala, Kelly R., et al.
Publicado: (2014) -
Disabled-2 downregulation promotes epithelial-to-mesenchymal transition
por: Martin, J C, et al.
Publicado: (2010) -
The role of the folate pathway in pancreatic cancer risk
por: Chittiboyina, Shirisha, et al.
Publicado: (2018) -
Progressive Susac syndrome with bilateral visual loss and disability
por: Entezari, Morteza, et al.
Publicado: (2016) -
Contribution of Environment and Genetics to Pancreatic Cancer Susceptibility
por: Hocevar, Barbara A., et al.
Publicado: (2014)